Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer. - Wikidata - wikimedia - TriplyDB

Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.

Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.

http://www.wikidata.org/entity/Q37637959

about

Sphingosine kinase 1 isoform-specific interactions in breast cancer Leptin induces upregulation of sphingosine kinase 1 in oestrogen receptor-negative breast cancer via Src family kinase-mediated, janus kinase 2-independent pathway TGFβ-Mediated induction of SphK1 as a potential determinant in human MDA-MB-231 breast cancer cell bone metastasis.The Sphingosine Kinase 2 Inhibitor ABC294640 Reduces the Growth of Prostate Cancer Cells and Results in Accumulation of Dihydroceramides In Vitro and In Vivo.Inhibition of p38 mitogen-activated protein kinase alters microRNA expression and reverses epithelial-to-mesenchymal transition.Therapeutic Strategies and Pharmacological Tools Influencing S1P Signaling and Metabolism.Protein Kinase Targets in Breast Cancer.Predictive value of sphingosine kinase 1 expression in neoadjuvant treatment of breast cancer.Expansion of Sphingosine Kinase and Sphingosine-1-Phosphate Receptor Function in Normal and Cancer Cells: From Membrane Restructuring to Mediation of Estrogen Signaling and Stem Cell Programming.Sphingosine kinase 2 supports the development of BCR/ABL-independent acute lymphoblastic leukemia in mice.A Phase I Study of ABC294640, a First-in-Class Sphingosine Kinase-2 Inhibitor, in Patients with Advanced Solid Tumors.

P2860

Q33631908-768C8840-E733-46D7-A327-2196A7AA0079 Q35000226-953BC5C1-E5F2-4AF2-B52A-9C816322748A Q35831148-45628FD0-E0D4-4A66-B897-9EF09A4D9F5E Q36359489-6A44AA47-5497-4064-86C7-2578D5E893FE Q36755634-81F6D02C-DAF7-4A64-AEA8-B8C377DE5E3F Q38915115-0330681F-0363-463B-81E9-270D4D680240 Q47351355-395D5D3C-08E3-4D2C-8F22-2AA6A8C772AA Q47753783-A5D1EBC5-2C82-438F-A4C5-9105C75F4B32 Q48134167-97693302-A1E7-4199-8B38-A0AAE9588A3A Q50021960-2814E7D3-E087-42A8-82B3-3040E5670AB9 Q55001442-576F4181-F02F-46D2-8BE7-D7EF94FE75D5

P2860

Sphingosine kinase isoforms as a therapeutic target in endocrine therapy resistant luminal and basal-A breast cancer.

http://www.wikidata.org/entity/Q37637959

description

article científic

@ca

article scientifique

@fr

articolo scientifico

@it

artigo científico

@pt

bilimsel makale

@tr

scientific article published on July 2012

@en

vedecký článok

@sk

vetenskaplig artikel

@sv

videnskabelig artikel

@da

vědecký článek

@cs

name

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@en

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@nl

type

label

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@en

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@nl

prefLabel

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@en

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@nl

P1433

Q37637959-B00565CD-903F-4D4A-9EFD-31BFC836D3DB

P1476

Q37637959-90B3282A-72FC-43C7-8B26-795F52F2E69F

P2093

Q37637959-0D6EE6E0-68BA-4DCB-8885-CE0F3411700E

Q37637959-6C4608CA-7EF2-4B60-BF06-26BF7C836AA5

Q37637959-6F527C47-CCBD-451C-A0AB-6F762CEA6E52

Q37637959-BBDEDDA9-8917-48BE-A5FA-FDA57BCF112F

Q37637959-DCB14C73-7DCF-40DE-BEB7-4E440EE72129

P2860

Q37637959-02146133-BD25-4319-B473-56EB92CC1ECD

Q37637959-053E5A26-5473-48BD-ABDB-12F980D660C6

Q37637959-07DCC693-2559-4157-9303-2F204E24DAE1

Q37637959-10917045-DD93-4002-A049-55FBB54D7D69

Q37637959-155CB02B-F349-400C-AE1B-E1474B11C091

Q37637959-1708D0F4-3F1D-4A64-B50B-29DF7BF86EA7

Q37637959-195FFB54-F818-4091-B3F2-47F576AD01AD

Q37637959-20791286-91AC-4FE6-BE54-962BDCD614DF

Q37637959-2327A5AA-3727-4210-9A17-B6C6967EE91B

Q37637959-23ED0DC7-F2B6-4738-B90B-B0CB8D38B61B

P304

Q37637959-6C05B3CA-53C6-423E-AC0F-41B58838648C

P31

Q37637959-F3FFD258-4AFA-4839-9952-B62333899031

P356

Q37637959-7A6F194D-41A2-4B52-BFC2-E465722B2CAD

P433

Q37637959-3F765D85-3268-406D-BA90-542B97D5AA4B

P478

Q37637959-D9BB69C3-0469-4B14-8A88-B113598E159D

P577

Q37637959-CF55841A-2B9F-4CF0-9A94-BD73BC73D887

P698

Q37637959-6558DDA0-8FC2-47E7-83A5-A07995C5EBAD

P932

Q37637959-BC0F1BBC-9C6D-44F9-8648-AAE2087CD57B

P356

EBM.2012.012028

P1433

Experimental Biology and Medicine

P1476

Sphingosine kinase isoforms as ...... nal and basal-A breast cancer.

@en

P2093

Barbara S Beckman

http://www.w3.org/2001/XMLSchema#string

James W Antoon

http://www.w3.org/2001/XMLSchema#string

Jennifer L Driver

http://www.w3.org/2001/XMLSchema#string

Martin D White

http://www.w3.org/2001/XMLSchema#string

Matthew E Burow

http://www.w3.org/2001/XMLSchema#string

P2860

Molecular cloning and functional characterization of a novel mammalian sphingosine kinase type 2 isoform

Sphingosine kinase mediates vascular endothelial growth factor-induced activation of ras and mitogen-activated protein kinases

Sphingosine kinase type 1 promotes estrogen-dependent tumorigenesis of breast cancer MCF-7 cells

Phosphorylation-dependent translocation of sphingosine kinase to the plasma membrane drives its oncogenic signalling

A collection of breast cancer cell lines for the study of functionally distinct cancer subtypes

BCL-2, BCL-X(L) sequester BH3 domain-only molecules preventing BAX- and BAK-mediated mitochondrial apoptosis

Identification of mitogen-activated protein kinase kinase as a chemoresistant pathway in MCF-7 cells by using gene expression microarray

PKC-dependent activation of sphingosine kinase 1 and translocation to the plasma membrane. Extracellular release of sphingosine-1-phosphate induced by phorbol 12-myristate 13-acetate (PMA)

Relevance of breast cancer cell lines as models for breast tumours: an update

Isolation and characterization of a spontaneously immortalized human breast epithelial cell line, MCF-10

P304

832-844

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1258/EBM.2012.012028

http://www.w3.org/2001/XMLSchema#string

P433

7

http://www.w3.org/2001/XMLSchema#string

P478

237

http://www.w3.org/2001/XMLSchema#string

P577

2012-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

22859737

http://www.w3.org/2001/XMLSchema#string

P932

3954577

http://www.w3.org/2001/XMLSchema#string